Taken together, these data indicate that targeting JAK2/STAT3 reduces the radioresistance of CRC cells by augmenting RT-induced apoptosis and decreasing the clonogenic potential of surviving cells after RT. This evidence concerns the gene STAT3 and colorectal carcinoma.